《股市简讯》中国康希诺A/H股齐升,曼海欣适用年龄范围扩大料对业绩有积极影响

路透中文
Yesterday
《股市简讯》中国<a href="https://laohu8.com/S/688185">康希诺</a>A/H股齐升,曼海欣适用年龄范围扩大料对业绩有积极影响

* 中国疫苗生产商--康希诺688185.SS6185.HK中港股周三早盘分别一度升2.3%和2.9%,

* 该公司此前公告称,公司产品ACYW135群脑膜炎球菌多糖结合疫苗(CRM197载体)适用人群年龄范围由“3月龄~3周岁(47月龄)儿童”扩大至“3月龄~6周岁(83月龄)儿童”。

该公司并称,曼海欣®的适用人群年龄范围扩大,预计对公司业绩将产生一定的积极影响。

* 中证医药100指数.CSI000978涨0.7%。

* 恒生生物科技指数.HSBIO涨0.4%。(完)

更多股市简讯请点选CN-CMN-HOT

(发稿 宿泱韫;审校 田镧沁)

((kaiwen.xu@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10